Business Context and Reporting Period
Company: Eastman Chemical Company
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2003
Business Overview: Eastman operates in three divisions: Eastman Division (Coatings, Adhesives, Specialty Polymers, and Inks; Performance Chemicals and Intermediates; Specialty Plastics), Voridian Division (Polymers; Fibers), and Developing Businesses Division. The company manufactures raw materials, additives, specialty polymers, and chemicals for various industrial and consumer applications.
Key Financial Metrics
| Metric (in millions, except per share) | Q3 2003 | Q3 2002 | 9 Months 2003 | 9 Months 2002 |
|---|---|---|---|---|
| Sales | $1,444 | $1,374 | $4,366 | $4,005 |
| Gross Profit | $200 | $202 | $625 | $636 |
| Gross Margin % | 13.9% | 14.7% | 14.3% | 15.9% |
| Operating Earnings (Loss) | $(440) | $61 | $(306) | $219 |
| Net Earnings (Loss) | $(336) | $24 | $(280) | $74 |
| Diluted EPS | $(4.35) | $0.31 | $(3.62) | $0.96 |
| Cash from Operations (9 Mo) | $46 | $541 | $46 | $541 |
| Total Debt (Borrowings) | $2,209 | $2,057 | $2,209 | $2,057 |
| Cash and Equivalents | $53 | $77 | $53 | $77 |
Material Changes vs. Prior Period
- Significant Losses: The company reported a net loss of $336 million for Q3 2003 and $280 million for the first nine months, compared to net earnings of $24 million and $74 million, respectively, in the prior year periods.
- Impairments and Restructuring: The primary driver of the loss was pre-tax impairments and restructuring charges of $496 million in Q3 2003 and $514 million for the first nine months.
- CASPI Segment: Recorded $411 million in charges (Q3) due to a strategic reorganization, including $194 million in fixed asset impairments, $175 million in intangible asset impairments, and $34 million in goodwill impairments.
- PCI Segment: Recorded $83 million in charges (Q3) related to fixed asset impairments due to increased competition and strategy changes.
- Revenue Growth: Sales increased 5% in Q3 and 9% for the first nine months compared to 2002. This growth was driven by higher selling prices and favorable foreign exchange rates (specifically the strengthening of the euro), which offset declines in sales volume.
- Margin Compression: Gross margins declined due to higher raw material and energy costs (propane, paraxylene, ethylene glycol, natural gas) and lower sales volumes.
- Cash Flow Decline: Net cash provided by operating activities dropped significantly to $46 million for the first nine months of 2003 from $541 million in 2002. This was largely due to a $238 million contribution to U.S. defined benefit pension plans and a decrease in liabilities for employee benefits.
Guidance, Outlook, and Risks
- 2003 Outlook: Management expects higher raw material and energy costs to continue negatively impacting results, partially offset by price increases and cost controls. The company anticipates full-year 2003 earnings to be close to break-even or slightly positive in the fourth quarter.
- Capital Allocation: Capital spending is expected to be approximately $260 million for 2003. The company plans to retire and refinance $500 million of debt maturing in January 2004 using cash from operations and new borrowings.
- Restructuring: The company continues to review its portfolio, particularly in the Eastman Division, and expects to pursue further restructuring, divestiture, and consolidation alternatives in the CASPI segment to improve profitability.
- Pension Funding: The company completed its expected 2003 funding of U.S. defined benefit pension plans with a $238 million contribution. Additional funding of $0 to $40 million may be required in 2004.
- Risks and Contingencies:
- Legal Proceedings: Ongoing sorbates litigation (price-fixing) and a significant increase in asbestos claims (approx. 11,000 claims). Management believes the ultimate resolution will not have a material adverse effect on overall financial condition, though it could impact earnings in specific periods.
- Market Conditions: Risks include global economic conditions, raw material availability and cost, foreign currency fluctuations, and competitive pressures, particularly in the CASPI and Fibers segments.
Investor Verification Checklist
- Impairment Details: Verify the specific assets written down in the CASPI and PCI segments and the assumptions used for fair value appraisals.
- Debt Maturity: Confirm the refinancing plan for the $500 million note maturing in January 2004 and the impact of the new $250 million note issued in November 2003.
- Pension Obligations: Review the sensitivity of pension expenses to changes in discount rates and expected returns on assets, as noted in the filing.
- Legal Exposure: Monitor the status of the sorbates class action lawsuits and the volume of asbestos claims, particularly in Mississippi.
- Cost Pass-Through: Assess the company's ability to pass on higher raw material and energy costs to customers without further volume erosion.